The lung microbiota in nontuberculous mycobacterial pulmonary disease.

The lung microbiota in nontuberculous mycobacterial pulmonary disease.

<h4>Background</h4>The role of bacterial microbiota in the pathogenesis of nontuberculous mycobacterial pulmonary disease (NTM-PD) is unclear. We aimed to compare the bacterial microbiome of disease-invaded lesions and non-invaded lung tissue from NTM-PD patients.<h4>Methods</h4...

Full description

Bibliographic Details
Main Authors:	Bo-Guen Kim, Noeul Kang, Su-Young Kim, Dae Hun Kim, Hojoong Kim, O Jung Kwon, Hee Jae Huh, Nam Yong Lee, Byung Woo Jhun
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0285143

Similar Items

Changes in sputum microbiota during treatment for nontuberculous mycobacterial pulmonary disease
by: Bo-Guen Kim, et al.
Published: (2023-11-01)

In Vitro Activity and Clinical Outcomes of Clofazimine for Nontuberculous Mycobacteria Pulmonary Disease
by: Dae Hun Kim, et al.
Published: (2021-10-01)

Clinical Characteristics and Outcomes of Surgically Resected Solitary Pulmonary Nodules Due to Nontuberculous Mycobacterial Infections
by: Yeonseok Choi, et al.
Published: (2019-11-01)

Risk factors for the development of chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease.
by: Byung Woo Jhun, et al.
Published: (2017-01-01)

Alterations in lung and gut microbiota reduce diversity in patients with nontuberculous mycobacterial pulmonary disease
by: Ji Yeon Choi, et al.
Published: (2023-11-01)

Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection
by: Young Jae Kim, et al.
Published: (2022-12-01)

Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory <i>Mycobacterium avium</i> Complex Pulmonary Disease
by: Bo-Guen Kim, et al.
Published: (2020-09-01)

Usefulness of the BACES score in nontuberculous mycobacterial pulmonary disease for various clinical outcomes
by: Hyung-Jun Kim, et al.
Published: (2023-05-01)

Clinical course of nontuberculous mycobacterial pulmonary disease in patients with rheumatoid arthritis
by: Nakwon Kwak, et al.
Published: (2024-03-01)

Nontuberculous mycobacterial pulmonary disease in a patient with unilateral pulmonary artery agenesis: Case report
by: Chang-Seok Yoon, et al.
Published: (2023-01-01)

High-Resolution CT Findings as Predictive Factors for Recurrent Nontuberculous Mycobacterial Pulmonary Disease after Successful Treatment
by: Hyewon Choi, et al.
Published: (2021-01-01)

The factors associated with mortality and progressive disease of nontuberculous mycobacterial lung disease: a systematic review and meta-analysis
by: Hyeontaek Hwang, et al.
Published: (2023-05-01)

Distinguishing nontuberculous mycobacterial lung disease and Mycobacterium tuberculosis lung disease on X-ray images using deep transfer learning
by: Minwoo Park, et al.
Published: (2023-01-01)

The Clinical Implications of Serum Carbohydrate Antigen 19-9 Levels in Patients with Nontuberculous Mycobacteria Pulmonary Disease
by: Daegeun Lee, et al.
Published: (2023-12-01)

Pulmonary Nontuberculous Mycobacterial Infection in Infants: A Systematic Review
by: Bai A, et al.
Published: (2021-12-01)

Risk Factors for the Development of Nontuberculous Mycobacteria Pulmonary Disease during Long-Term Follow-Up after Lung Cancer Surgery
by: Bo-Guen Kim, et al.
Published: (2022-04-01)

Chronic Pulmonary Aspergillosis Following Nontuberculous Mycobacterial Infections: An Emerging Disease
by: Pakpoom Phoompoung, et al.
Published: (2020-12-01)

Osteoporosis in nontuberculous mycobacterial pulmonary disease: a cross-sectional study
by: Hiromu Tanaka, et al.
Published: (2022-05-01)

Molecular assessment of mycobacterial burden in the treatment of nontuberculous mycobacterial disease
by: Huw C. Ellis, et al.
Published: (2023-03-01)

Real-World Outcomes of Amikacin Liposome Inhalation Suspension for Refractory Complex Pulmonary Disease
by: Bo-Guen Kim, et al.
Published: (2024-04-01)

A Prospective Cohort Study of Bioavailable 25-Hydroxyvitamin D Levels as a Marker of Vitamin D Status in Nontuberculous Mycobacterial Pulmonary Disease
by: Byoung-Soo Kwon, et al.
Published: (2021-07-01)

Characteristics and comparison of rapidly growing and slowly growing nontuberculous mycobacterial pulmonary disease
by: Daibing Zhou, et al.
Published: (2023-01-01)

The diagnostic yield and characteristics of bronchoalveolar lavage in suspected nontuberculous mycobacterial pulmonary disease
by: Shigehisa Kajikawa, et al.
Published: (2022-01-01)

Nontuberculous Mycobacterial Infection after Aesthetic Procedures: Diagnosis and Treatment Insights from a Retrospective Study
by: Byeongseok Kim, MD, et al.
Published: (2023-10-01)

Clinico-microbiological Profile of Nontuberculous Mycobacterial Keratitis
by: Richa Dhiman, et al.
Published: (2022-05-01)

Decreased Interleukin-1 Family Cytokine Production in Patients with Nontuberculous Mycobacterial Lung Disease
by: Bock-Gie Jung, et al.
Published: (2022-12-01)

Computed Tomography in Adults with Bronchiectasis and Nontuberculous Mycobacterial Pulmonary Disease: Typical Imaging Findings
by: Sabine Dettmer, et al.
Published: (2021-06-01)

Incremental mortality associated with nontuberculous mycobacterial lung disease among US Medicare beneficiaries with chronic obstructive pulmonary disease
by: Ping Wang, et al.
Published: (2023-11-01)

A Comparison of Clinical and Radiographic Signs of Nontuberculous Mycobacterial Pulmonary Disease, Destructive Drug-Resistant Pulmonary Tuberculosis and a Combination of Nontuberculous Mycobacterium Pulmonary Disease and Pulmonary Tuberculosis
by: Dmitrii Giller, et al.
Published: (2023-06-01)

Spontaneous Cultural Conversion Rate of <i>Mycobacterium avium</i> Complex Pulmonary Disease Based on BACES Severity
by: Bo-Guen Kim, et al.
Published: (2023-11-01)

Editorial: Host-pathogen interactions in nontuberculous mycobacterial infections
by: Nicola Ivan Lorè, et al.
Published: (2023-05-01)

Difficulty in diagnosis and management of musculoskeletal nontuberculous mycobacterial infections
by: Faith I. Vietor, et al.
Published: (2022-01-01)

Nontuberculous mycobacterial skin and soft tissue infection in Hawaiʻi
by: Darcy S. Tokunaga, et al.
Published: (2022-04-01)

Nontuberculous Mycobacterial Lung Disease in the Patients with Cystic Fibrosis—A Challenging Diagnostic Problem
by: Dorota Wyrostkiewicz, et al.
Published: (2022-06-01)

The impact of nontuberculous mycobacterial lung disease in critically ill patients: Significance for survival and ventilator use
by: Ying-Chun Chien, et al.
Published: (2024-04-01)

Clinical Characteristics and Treatment Outcomes of Mycobacterium fortuitum Pulmonary Disease
by: Sae Rom Kim, et al.
Published: (2023-08-01)

Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease
by: Xuanyou Jin, et al.
Published: (2020-11-01)

Inhaled Corticosteroids and the Risk of Nontuberculous Mycobacterial Pulmonary Disease in Chronic Obstructive Pulmonary Disease: Findings from a Nationwide Population-Based Study
by: Iseul Yu, et al.
Published: (2023-06-01)

First Case Reports of Nontuberculous Mycobacterial (NTM) Lung Disease in Ecuador: Important Lessons to Learn
by: Gustavo Echeverria, et al.
Published: (2023-03-01)

Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study
by: Kohei Fujita, et al.
Published: (2022-11-01)